SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-007949
Filing Date
2015-11-10
Accepted
2015-11-10 21:58:46
Documents
3
Period of Report
2015-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7852
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 5023
3 EX-24.2 DOCUMENT attachment2.htm EX-24.2 5028
  Complete submission text file 0000899243-15-007949.txt   20082
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE. CAMBRIDGE MA 02138
Business Address
TAKANASHI KEN (Reporting) CIK: 0001657768 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37627 | Film No.: 151220965

Mailing Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394
Business Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394 81-99-294-2600
Shin Nippon Biomedical Laboratories, Ltd. (Reporting) CIK: 0001657770 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37627 | Film No.: 151220964